{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:02:40Z","timestamp":1794344560500,"version":"4.9.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS055349"],"award-info":[{"award-number":["R01NS055349"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43 TW010928"],"award-info":[{"award-number":["D43 TW010928"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01 HD064698"],"award-info":[{"award-number":["U01 HD064698"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In 2011, the World Health Organization recommended injectable artesunate as the first-line therapy for severe malaria (SM) due to its superiority in reducing mortality compared to quinine. There are limited data on long-term clinical and neurobehavioral outcomes after artemisinin use for treatment of SM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From 2008 to 2013, 502 Ugandan children with two common forms of SM, cerebral malaria and severe malarial anemia, were enrolled in a prospective observational study assessing long-term neurobehavioral and cognitive outcomes following SM. Children were evaluated a week after hospital discharge, and 6, 12, and 24 months of follow-up, and returned to hospital for any illness. In this study, we evaluated the impact of artemisinin derivatives on survival, post-discharge hospital readmission or death, and neurocognitive and behavioral outcomes over 2 years of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>346 children received quinine and 156 received parenteral artemisinin therapy (artemether or artesunate). After adjustment for disease severity, artemisinin derivatives were associated with a 78% reduction in in-hospital mortality (adjusted odds ratio, 0.22; 95% CI, 0.07\u20130.67). Among cerebral malaria survivors, children treated with artemisinin derivatives also had reduced neurologic deficits at discharge (quinine, 41.7%; artemisinin derivatives, 23.7%, <jats:italic>p<\/jats:italic>=0.007). Over a 2-year follow-up, artemisinin derivatives as compared to quinine were associated with better adjusted scores (negative scores better) in internalizing behavior and executive function in children irrespective of the age at severe malaria episode. After adjusting for multiple comparisons, artemisinin derivatives were associated with better adjusted scores in behavior and executive function in children &lt;6 years of age at severe malaria exposure following adjustment for child age, sex, socioeconomic status, enrichment in the home environment, and the incidence of hospitalizations over follow-up. Children receiving artesunate had the greatest reduction in mortality and benefit in behavioral outcomes and had reduced inflammation at 1-month follow-up compared to children treated with quinine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Treatment of severe malaria with artemisinin derivatives, particularly artesunate, results in reduced in-hospital mortality and neurologic deficits in children of all ages, reduced inflammation following recovery, and better long-term behavioral outcomes. These findings suggest artesunate has long-term beneficial effects in children surviving severe malaria.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-021-02033-1","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T01:02:32Z","timestamp":1627434152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malaria"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5328-6511","authenticated-orcid":false,"given":"Andrea L.","family":"Conroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert O.","family":"Opoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bangirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Namazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen E.","family":"Okullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Georgieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cusick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Idro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Ssenkusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandy C.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,28]]},"reference":[{"key":"2033_CR1","unstructured":"WHO: World malaria report 2019. In., vol. Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2019."},{"issue":"9753","key":"2033_CR2","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0140-6736(10)61924-1","volume":"376","author":"AM Dondorp","year":"2010","unstructured":"Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(10)61924-1.","journal-title":"Lancet"},{"issue":"5","key":"2033_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0035-9203(99)90368-1","volume":"93","author":"PA Holding","year":"1999","unstructured":"Holding PA, Stevenson J, Peshu N, Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hygiene. 1999;93(5):529\u201334. https:\/\/doi.org\/10.1016\/S0035-9203(99)90368-1.","journal-title":"Trans R Soc Trop Med Hygiene"},{"issue":"1","key":"2033_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-3156.2004.01345.x","volume":"10","author":"JA Carter","year":"2005","unstructured":"Carter JA, Ross AJ, Neville BG, Obiero E, Katana K, Mung'ala-Odera V, et al. Developmental impairments following severe falciparum malaria in children. Trop Med Int Health. 2005;10(1):3\u201310. https:\/\/doi.org\/10.1111\/j.1365-3156.2004.01345.x.","journal-title":"Trop Med Int Health"},{"issue":"4","key":"2033_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp.2004.043893","volume":"76","author":"JA Carter","year":"2005","unstructured":"Carter JA, Mung'ala-Odera V, Neville BG, Murira G, Mturi N, Musumba C, et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry. 2005;76(4):476\u201381. https:\/\/doi.org\/10.1136\/jnnp.2004.043893.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2033_CR6","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1542\/peds.2007-3709","volume":"122","author":"CC John","year":"2008","unstructured":"John CC, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics. 2008;122(1):e92\u20139. https:\/\/doi.org\/10.1542\/peds.2007-3709.","journal-title":"Pediatrics"},{"issue":"2","key":"2033_CR7","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1542\/peds.2006-2027","volume":"119","author":"MJ Boivin","year":"2007","unstructured":"Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119(2):e360\u20136. https:\/\/doi.org\/10.1542\/peds.2006-2027.","journal-title":"Pediatrics"},{"issue":"5","key":"2033_CR8","doi-asserted-by":"publisher","first-page":"e20161965","DOI":"10.1542\/peds.2016-1965","volume":"138","author":"JM Ssenkusu","year":"2016","unstructured":"Ssenkusu JM, Hodges JS, Opoka RO, Idro R, Shapiro E, John CC, et al. Long-term behavioral problems in children with severe malaria. Pediatrics. 2016;138(5):e20161965. https:\/\/doi.org\/10.1542\/peds.2016-1965.","journal-title":"Pediatrics"},{"issue":"3","key":"2033_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/cid\/ciu293","volume":"59","author":"P Bangirana","year":"2014","unstructured":"Bangirana P, Opoka RO, Boivin MJ, Idro R, Hodges JS, Romero RA, et al. Severe malarial anemia is associated with long-term neurocognitive impairment. Clin Infect Dis. 2014;59(3):336\u201344. https:\/\/doi.org\/10.1093\/cid\/ciu293.","journal-title":"Clin Infect Dis"},{"key":"2033_CR10","doi-asserted-by":"publisher","unstructured":"Langfitt JT, McDermott MP, Brim R, Mboma S, Potchen MJ, Kampondeni SD, Seydel KB, Semrud-Clikeman M, Taylor TE. Neurodevelopmental impairments 1 year after cerebral malaria. Pediatrics 2019;143(2).e20181026. https:\/\/doi.org\/10.1542\/peds.2018-1026.","DOI":"10.1542\/peds.2018-1026"},{"issue":"3","key":"2033_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1473-3099(11)70320-6","volume":"12","author":"K Phiri","year":"2012","unstructured":"Phiri K, Esan M, van Hensbroek MB, Khairallah C, Faragher B, ter Kuile FO. Intermittent preventive therapy for malaria with monthly artemether\u2013lumefantrine for the post-discharge management of severe anaemia in children aged 4\u201359 months in southern Malawi: a multicentre, randomised, placebo-controlled trial. Lancet Infect Dis. 2012;12(3):191\u2013200. https:\/\/doi.org\/10.1016\/S1473-3099(11)70320-6.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"2033_CR12","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1093\/jpids\/piw060","volume":"6","author":"RO Opoka","year":"2017","unstructured":"Opoka RO, Hamre KES, Brand N, Bangirana P, Idro R, John CC. High postdischarge morbidity in Ugandan children with severe malarial anemia or cerebral malaria. J Pediatric Infect Dis Soc. 2017;6(3):e41\u20138. https:\/\/doi.org\/10.1093\/jpids\/piw060.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"6","key":"2033_CR13","first-page":"777","volume":"70","author":"K Win","year":"1992","unstructured":"Win K, Than M, Thwe Y. Comparison of combinations of parenteral artemisinin derivatives plus oral mefloquine with intravenous quinine plus oral tetracycline for treating cerebral malaria. Bull World Health Organ. 1992;70(6):777\u201382.","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2033_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/0035-9203(92)90137-2","volume":"86","author":"TT Hien","year":"1992","unstructured":"Hien TT, Arnold K, Vinh H, Cuong BM, Phu NH, Chau TTH, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg. 1992;86(6):582\u20133. https:\/\/doi.org\/10.1016\/0035-9203(92)90137-2.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"2033_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s0035-9203(97)90099-7","volume":"91","author":"XT Cao","year":"1997","unstructured":"Cao XT, Bethell DB, Pham TP, Ta TT, Tran TN, Nguyen TT, et al. Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria. Trans R Soc Trop Med Hyg. 1997;91(3):335\u201342. https:\/\/doi.org\/10.1016\/s0035-9203(97)90099-7.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"2033_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1086\/375059","volume":"37","author":"PN Newton","year":"2003","unstructured":"Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, et al. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis. 2003;37(1):7\u201316. https:\/\/doi.org\/10.1086\/375059.","journal-title":"Clin Infect Dis"},{"issue":"9487","key":"2033_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(05)67176-0","volume":"366","author":"A Dondorp","year":"2005","unstructured":"Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunte Malaria Trial group. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet. 2005;366(9487):717\u201325. https:\/\/doi.org\/10.1016\/S0140-6736(05)67176-0.","journal-title":"Lancet"},{"issue":"10","key":"2033_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.trstmh.2010.05.009","volume":"104","author":"HG Eltahir","year":"2010","unstructured":"Eltahir HG, Omer AA, Mohamed AA, Adam I. Comparison of artesunate and quinine in the treatment of Sudanese children with severe Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg. 2010;104(10):684\u20136. https:\/\/doi.org\/10.1016\/j.trstmh.2010.05.009.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2033_CR19","volume-title":"Management of severe malaria: a practical handbook - 3rd ed","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: Management of severe malaria: a practical handbook - 3rd ed. 2013"},{"issue":"8","key":"2033_CR20","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-3156.2004.01277.x","volume":"9","author":"D Njama-Meya","year":"2004","unstructured":"Njama-Meya D, Kamya MR, Dorsey G. Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. Tro Med Int Health. 2004;9(8):862\u20138. https:\/\/doi.org\/10.1111\/j.1365-3156.2004.01277.x.","journal-title":"Tro Med Int Health"},{"issue":"5","key":"2033_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/ajcn\/nqaa004","volume":"111","author":"SE Cusick","year":"2020","unstructured":"Cusick SE, Opoka RO, Ssemata AS, Georgieff MK, John CC. Delayed iron improves iron status without altering malaria risk in severe malarial anemia. Am J Clin Nutr. 2020;111(5):1059\u201367. https:\/\/doi.org\/10.1093\/ajcn\/nqaa004.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2033_CR22","doi-asserted-by":"publisher","first-page":"ofx151","DOI":"10.1093\/ofid\/ofx151","volume":"4","author":"GS Park","year":"2017","unstructured":"Park GS, Opoka RO, Shabani E, Wypyszynski A, Hanisch B, John CC. Plasmodium falciparum histidine-rich protein-2 plasma concentrations are higher in retinopathy-negative cerebral malaria than in severe malarial anemia. Open Forum Infect Dis. 2017;4(3):ofx151.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2033_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/1756-0500-3-104","volume":"3","author":"R Idro","year":"2010","unstructured":"Idro R, Kakooza-Mwesige A, Balyejjussa S, Mirembe G, Mugasha C, Tugumisirize J, et al. Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes. 2010;3(1):104. https:\/\/doi.org\/10.1186\/1756-0500-3-104.","journal-title":"BMC Res Notes"},{"key":"2033_CR24","volume-title":"Mullen scales of early learning. In., edn","author":"E Mullen","year":"1995","unstructured":"Mullen E. Mullen scales of early learning. In., edn. Circle Pines: American Guidance Services Inc.; 1995."},{"issue":"1","key":"2033_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/09297040601100430","volume":"14","author":"CM Jordan","year":"2008","unstructured":"Jordan CM, Johnson AL, Hughes SJ, Shapiro EG. The Color Object Association Test (COAT): the development of a new measure of declarative memory for 18- to 36-month-old toddlers. Child Neuropsychol. 2008;14(1):21\u201341. https:\/\/doi.org\/10.1080\/09297040601100430.","journal-title":"Child Neuropsychol"},{"issue":"3","key":"2033_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1207\/s15326942dn2503_1","volume":"25","author":"DZ Goldman","year":"2004","unstructured":"Goldman DZ, Shapiro EG, Nelson CA. Measurement of vigilance in 2-year-old children. Dev Neuropsychol. 2004;25(3):227\u201350. https:\/\/doi.org\/10.1207\/s15326942dn2503_1.","journal-title":"Dev Neuropsychol"},{"key":"2033_CR27","volume-title":"KN: Kaufman assessment battery for children manual 2nd edition","author":"AS Kaufman","year":"2004","unstructured":"Kaufman AS. KN: Kaufman assessment battery for children manual 2nd edition. Circle Pines: American Guidance Service; 2004."},{"issue":"6","key":"2033_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1469-7610.1993.tb01105.x","volume":"34","author":"LM Greenberg","year":"1993","unstructured":"Greenberg LM, Waldmant ID. Developmental normative data on the test of variables of attention (T.O.V.A.\u2122). J Child Psychol Psychiatry. 1993;34(6):1019\u201330. https:\/\/doi.org\/10.1111\/j.1469-7610.1993.tb01105.x.","journal-title":"J Child Psychol Psychiatry"},{"issue":"8","key":"2033_CR29","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1542\/pir.21-8-265","volume":"21","author":"TM Achenbach","year":"2000","unstructured":"Achenbach TM, Ruffle TM. The Child Behavior Checklist and related forms for assessing behavioral\/emotional problems and competencies. Pediatr Rev. 2000;21(8):265\u201371. https:\/\/doi.org\/10.1542\/pir.21-8-265.","journal-title":"Pediatr Rev"},{"issue":"3","key":"2033_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1076\/chin.6.3.235.3152","volume":"6","author":"GA Gioia","year":"2000","unstructured":"Gioia GA, Isquith PK, Guy SC, Kenworthy L. Test review behavior rating inventory of executive function. Child Neuropsychol. 2000;6(3):235\u20138. https:\/\/doi.org\/10.1076\/chin.6.3.235.3152.","journal-title":"Child Neuropsychol"},{"issue":"12","key":"2033_CR31","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2471\/BLT.08.060327","volume":"87","author":"HH Kyu","year":"2009","unstructured":"Kyu HH, Fern\u00e1ndez E. Artemisinin derivatives versus quinine for cerebral malaria in African children: a systematic review. Bull World Health Organ. 2009;87(12):896\u2013904. https:\/\/doi.org\/10.2471\/BLT.08.060327.","journal-title":"Bull World Health Organ"},{"issue":"3","key":"2033_CR32","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4269\/ajtmh.1994.51.251","volume":"51","author":"TG Brewer","year":"1994","unstructured":"Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, et al. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg. 1994;51(3):251\u20139. https:\/\/doi.org\/10.4269\/ajtmh.1994.51.251.","journal-title":"Am J Trop Med Hyg"},{"issue":"Suppl 1","key":"2033_CR33","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/0035-9203(94)90469-3","volume":"88","author":"TG Brewer","year":"1994","unstructured":"Brewer TG, Peggins JO, Grate SJ, Petras JM, Levine BS, Weina PJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg. 1994;88(Suppl 1):S33\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"2033_CR34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.4269\/ajtmh.1998.59.519","volume":"59","author":"A Nontprasert","year":"1998","unstructured":"Nontprasert A, Nosten-Bertrand M, Pukrittayakamee S, Vanijanonta S, Angus BJ, White NJ. Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice. Am J Trop Med Hyg. 1998;59(4):519\u201322. https:\/\/doi.org\/10.4269\/ajtmh.1998.59.519.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"2033_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4269\/ajtmh.2002.67.423","volume":"67","author":"A Nontprasert","year":"2002","unstructured":"Nontprasert A, Pukrittayakamee S, Dondorp AM, Clemens R, Looareesuwan S, White NJ. Neuropathologic toxicity of artemisinin derivatives in a mouse model. Am J Trop Med Hyg. 2002;67(4):423\u20139. https:\/\/doi.org\/10.4269\/ajtmh.2002.67.423.","journal-title":"Am J Trop Med Hyg"},{"issue":"590","key":"2033_CR36","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fneur.2018.00590","volume":"9","author":"E Gugliandolo","year":"2018","unstructured":"Gugliandolo E, D'Amico R, Cordaro M, Fusco R, Siracusa R, Crupi R, et al. Neuroprotective effect of artesunate in experimental model of traumatic brain injury. Front Neurol. 2018;9(590):590. https:\/\/doi.org\/10.3389\/fneur.2018.00590.","journal-title":"Front Neurol"},{"issue":"1","key":"2033_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/1475-2875-12-388","volume":"12","author":"AS Miranda","year":"2013","unstructured":"Miranda AS, Brant F, Rocha NP, Cisalpino D, Rodrigues DH, Souza DG, et al. Further evidence for an anti-inflammatory role of artesunate in experimental cerebral malaria. Malar J. 2013;12(1):388. https:\/\/doi.org\/10.1186\/1475-2875-12-388.","journal-title":"Malar J"},{"issue":"2","key":"2033_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/INF.0000000000001382","volume":"36","author":"CR McDonald","year":"2017","unstructured":"McDonald CR, Conroy AL, Hawkes M, Elphinstone RE, Gamble JL, Hayford K, et al. Brain-derived neurotrophic factor is associated with disease severity and clinical outcome in Ugandan children admitted to hospital with severe malaria. Pediatr Infect Dis J. 2017;36(2):146\u201350. https:\/\/doi.org\/10.1097\/INF.0000000000001382.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2033_CR39","doi-asserted-by":"publisher","first-page":"e0215304","DOI":"10.1371\/journal.pone.0215304","volume":"14","author":"SKG Jensen","year":"2019","unstructured":"Jensen SKG, Tofail F, Haque R, Petri WA Jr, Nelson CA 3rd. Child development in the context of biological and psychosocial hazards among poor families in Bangladesh. Plos One. 2019;14(5):e0215304. https:\/\/doi.org\/10.1371\/journal.pone.0215304.","journal-title":"Plos One"},{"issue":"3","key":"2033_CR40","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/QAD.0000000000000072","volume":"28","author":"S Kapetanovic","year":"2014","unstructured":"Kapetanovic S, Griner R, Zeldow B, Nichols S, Leister E, Gelbard HA, et al. Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis. AIDS (London). 2014;28(3):355\u201364.","journal-title":"AIDS (London)"},{"issue":"1","key":"2033_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1097\/QAI.0000000000002314","volume":"84","author":"J Hoare","year":"2020","unstructured":"Hoare J, Myer L, Heany S, Fouche JP, Phillips N, Zar HJ, et al. Cognition, structural brain changes, and systemic inflammation in adolescents living with HIV on antiretroviral therapy. J Acquir Immune Defic Syndr. 2020;84(1):114\u201321.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2033_CR42","doi-asserted-by":"publisher","first-page":"974","DOI":"10.4269\/ajtmh.17-0083","volume":"97","author":"NM Jiang","year":"2017","unstructured":"Jiang NM, Tofail F, Ma JZ, Haque R, Kirkpatrick B, Nelson CA, et al. Early life inflammation and neurodevelopmental outcome in Bangladeshi infants growing up in adversity. Am J Trop Med Hyg. 2017;97(3):974\u20139. https:\/\/doi.org\/10.4269\/ajtmh.17-0083.","journal-title":"Am J Trop Med Hyg"},{"key":"2033_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/neuro.08.014.2009","volume":"3","author":"SD Bilbo","year":"2009","unstructured":"Bilbo SD, Schwarz JM. Early-life programming of later-life brain and behavior: a critical role for the immune system. Front Behav Neurosci. 2009;3:14.","journal-title":"Front Behav Neurosci"},{"issue":"9","key":"2033_CR44","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molmed.2018.06.008","volume":"24","author":"NM Jiang","year":"2018","unstructured":"Jiang NM, Cowan M, Moonah SN, Petri WA Jr. The impact of systemic inflammation on neurodevelopment. Trends Mol Med. 2018;24(9):794\u2013804. https:\/\/doi.org\/10.1016\/j.molmed.2018.06.008.","journal-title":"Trends Mol Med"},{"issue":"9556","key":"2033_CR45","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0140-6736(07)60076-2","volume":"369","author":"SP Walker","year":"2007","unstructured":"Walker SP, Wachs TD, Meeks Gardner J, Lozoff B, Wasserman GA, Pollitt E, et al. Child development: risk factors for adverse outcomes in developing countries. Lancet. 2007;369(9556):145\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(07)60076-2.","journal-title":"Lancet"},{"issue":"Supplement 1","key":"2033_CR46","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1542\/peds.2016-2828G","volume":"139","author":"NF Krebs","year":"2017","unstructured":"Krebs NF, Lozoff B, Georgieff MK. Neurodevelopment: the impact of nutrition and inflammation during infancy in low-resource settings. Pediatrics. 2017;139(Supplement 1):S50\u20138.","journal-title":"Pediatrics"},{"key":"2033_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2016.05.013","volume":"175","author":"SE Cusick","year":"2016","unstructured":"Cusick SE, Georgieff MK. The role of nutrition in brain development: the golden opportunity of the \u201cfirst 1000 days\u201d. J Pediatr. 2016;175:16\u201321. https:\/\/doi.org\/10.1016\/j.jpeds.2016.05.013.","journal-title":"J Pediatr"},{"issue":"5","key":"2033_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0020-7519(96)89380-5","volume":"26","author":"TS Skinner","year":"1996","unstructured":"Skinner TS, Manning LS, Johnston WA, Davis TM. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int J Parasitol. 1996;26(5):519\u201325. https:\/\/doi.org\/10.1016\/0020-7519(96)89380-5.","journal-title":"Int J Parasitol"},{"issue":"12","key":"2033_CR49","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1128\/AAC.46.12.3933-3939.2002","volume":"46","author":"C Nealon","year":"2002","unstructured":"Nealon C, Dzeing A, Muller-Romer U, Planche T, Sinou V, Kombila M, et al. Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria. Antimicrob Agents Chemother. 2002;46(12):3933\u20139. https:\/\/doi.org\/10.1128\/AAC.46.12.3933-3939.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2033_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1128\/AAC.45.1.181-186.2001","volume":"45","author":"TM Davis","year":"2001","unstructured":"Davis TM, Phuong HL, Ilett KF, Hung NC, Batty KT, Phuong VD, et al. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother. 2001;45(1):181\u20136. https:\/\/doi.org\/10.1128\/AAC.45.1.181-186.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"2033_CR51","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1128\/AAC.48.11.4234-4239.2004","volume":"48","author":"TT Hien","year":"2004","unstructured":"Hien TT, Davis TM, Chuong LV, Ilett KF, Sinh DX, Phu NH, et al. Comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria. Antimicrob Agents Chemother. 2004;48(11):4234\u20139. https:\/\/doi.org\/10.1128\/AAC.48.11.4234-4239.2004.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2033_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0035-9203(97)90097-3","volume":"91","author":"SA Murphy","year":"1997","unstructured":"Murphy SA, Mberu E, Muhia D, English M, Crawley J, Waruiru C, et al. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg. 1997;91(3):331\u20134. https:\/\/doi.org\/10.1016\/S0035-9203(97)90097-3.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"2033_CR53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1046\/j.1365-2125.2003.01986.x","volume":"57","author":"S Mithwani","year":"2004","unstructured":"Mithwani S, Aarons L, Kokwaro GO, Majid O, Muchohi S, Edwards G, et al. Population pharmacokinetics of artemether and dihydroartemisinin following single intramuscular dosing of artemether in African children with severe falciparum malaria. Br J Clin Pharmacol. 2004;57(2):146\u201352. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01986.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"2033_CR54","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s13063-018-2972-1","volume":"19","author":"TK Kwambai","year":"2018","unstructured":"Kwambai TK, Dhabangi A, Idro R, Opoka R, Kariuki S, Samuels AM, et al. Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial. Trials. 2018;19(1):610. https:\/\/doi.org\/10.1186\/s13063-018-2972-1.","journal-title":"Trials"},{"issue":"23","key":"2033_CR55","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1056\/NEJMoa2002820","volume":"383","author":"TK Kwambai","year":"2020","unstructured":"Kwambai TK, Dhabangi A, Idro R, Opoka R, Watson V, Kariuki S, et al. Malaria chemoprevention in the postdischarge management of severe anemia. N Engl J Med. 2020;383(23):2242\u201354. https:\/\/doi.org\/10.1056\/NEJMoa2002820.","journal-title":"N Engl J Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02033-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02033-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T01:02:45Z","timestamp":1627434165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02033-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,28]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2033"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02033-1","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,28]]},"assertion":[{"value":"3 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from parents\/guardians of study participants. Ethical approval was granted by the Institutional Review Boards at the Makerere University School of Medicine (SOMREC, reference number: 2008-033, date of first approval: April 7, 2008) and the University of Minnesota (IRB Code Number: 0808M27022, date of first approval: March 31, 2008). The study was also approved by the Uganda National Council for Science and Technology (UNCST, reference number: HS432, date of first approval, May 16, 2008).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Chandy John is a member of the editorial board of BMC Medicine. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"168"}}